OneMedNet (ONMD) restores Nasdaq listing compliance after meeting $35M value test

Rhea-AI Filing Summary

OneMedNet Corporation has regained compliance with Nasdaq’s continued listing standards. The company previously received a notice on March 12, 2025 stating that its market value of listed securities had fallen below the required $35,000,000 threshold under Nasdaq Listing Rule 5550(b)(2).

Nasdaq staff has now notified OneMedNet that for 10 consecutive business days, from August 27, 2025 to September 10, 2025, the company’s market value of listed securities was at or above $35,000,000. As a result, OneMedNet is again in compliance with Nasdaq Listing Rule 5550(b)(2), and Nasdaq considers the matter closed, allowing its common stock and warrants to remain listed on The Nasdaq Capital Market.

Positive

• Nasdaq listing compliance restored: OneMedNet’s market value of listed securities met or exceeded $35,000,000 for 10 consecutive business days, bringing it back into compliance with Nasdaq Listing Rule 5550(b)(2) and closing the deficiency matter.

Negative

• None.

Insights

Equity listing & market-structure analyst

OneMedNet has restored compliance with Nasdaq’s market value rule, closing a prior listing deficiency.

The company had been under pressure since a March 12, 2025 notice from Nasdaq staff that its market value of listed securities was below the required $35,000,000 for The Nasdaq Capital Market under Rule 5550(b)(2). Such a deficiency can eventually lead to delisting if not remedied within the grace period, which can affect liquidity and perception among investors.

The new notice states that for 10 consecutive business days, from August 27, 2025 to September 10, 2025, OneMedNet’s market value of listed securities was at least $35,000,000. Nasdaq now deems the company back in compliance and has closed the matter. This removes the immediate overhang of a potential delisting tied to this specific rule, although ongoing compliance with Nasdaq’s other listing criteria will remain important in future company disclosures.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Understanding 8-K Material Events →

false 0001849380 0001849380 2025-09-11 2025-09-11 0001849380 ONMD:CommonStock0.0001ParValuePerShareMember 2025-09-11 2025-09-11 0001849380 ONMD:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-09-11 2025-09-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 11, 2025

ONEMEDNET CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		001-40386		86-2076743
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: 800-918-7189

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		ONMD		The Nasdaq Stock Market LLC
Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share		ONMDW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

As previously disclosed, on March 12, 2025, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it had failed to maintain a minimum market value of listed securities of $35,000,000 required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2), and providing a grace period until September 2025 to regain compliance.

On September 11, 2025, the Company received notice (the “Notice”) from the Staff notifying the Company that the Staff had determined that for the last 10 consecutive business days, from August 27, 2025 to September 10, 2025, the Company’s market value of listed securities had been $35,000,000 or greater, and accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(b)(2) and the matter is now closed.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: September 15, 2025

	ONEMEDNET CORPORATION
	By:	/s/ Aaron Green
		Aaron Green
		Chief Executive Officer

FAQ

What did OneMedNet (ONMD) announce in this 8-K filing?

The company announced that Nasdaq staff has confirmed OneMedNet regained compliance with Nasdaq Listing Rule 5550(b)(2) after its market value of listed securities met the required level for 10 consecutive business days.

Why was OneMedNet (ONMD) previously out of compliance with Nasdaq rules?

On March 12, 2025, Nasdaq staff notified OneMedNet that its market value of listed securities had fallen below the $35,000,000 minimum required for continued listing on The Nasdaq Capital Market under Listing Rule 5550(b)(2).

How did OneMedNet (ONMD) regain compliance with Nasdaq Listing Rule 5550(b)(2)?

Nasdaq determined that from August 27, 2025 to September 10, 2025, OneMedNet’s market value of listed securities was $35,000,000 or greater for 10 consecutive business days, satisfying the rule’s requirement.

What is the minimum market value requirement that applies to OneMedNet (ONMD)?

Under Nasdaq Listing Rule 5550(b)(2), OneMedNet must maintain a minimum market value of listed securities of $35,000,000 to remain listed on The Nasdaq Capital Market.

Is the Nasdaq compliance issue for OneMedNet (ONMD) now resolved?

Yes. Nasdaq staff informed OneMedNet that it has regained compliance with Listing Rule 5550(b)(2) and that the market value of listed securities deficiency matter is now closed.

Which OneMedNet securities are listed on Nasdaq?

OneMedNet’s common stock, par value $0.0001 per share, trades under the symbol ONMD, and its redeemable warrants, exercisable at $11.50 per share of common stock, trade under the symbol ONMDW on The Nasdaq Stock Market LLC.